1. Home
  2. EQR vs RMD Comparison

EQR vs RMD Comparison

Compare EQR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQR
  • RMD
  • Stock Information
  • Founded
  • EQR 1993
  • RMD 1989
  • Country
  • EQR United States
  • RMD United States
  • Employees
  • EQR N/A
  • RMD N/A
  • Industry
  • EQR Real Estate Investment Trusts
  • RMD Medical/Dental Instruments
  • Sector
  • EQR Real Estate
  • RMD Health Care
  • Exchange
  • EQR Nasdaq
  • RMD Nasdaq
  • Market Cap
  • EQR 27.2B
  • RMD 31.8B
  • IPO Year
  • EQR 1993
  • RMD 1995
  • Fundamental
  • Price
  • EQR $69.97
  • RMD $245.08
  • Analyst Decision
  • EQR Buy
  • RMD Buy
  • Analyst Count
  • EQR 16
  • RMD 13
  • Target Price
  • EQR $78.69
  • RMD $259.40
  • AVG Volume (30 Days)
  • EQR 2.0M
  • RMD 1.2M
  • Earning Date
  • EQR 04-29-2025
  • RMD 04-23-2025
  • Dividend Yield
  • EQR 3.96%
  • RMD 0.86%
  • EPS Growth
  • EQR 8.50
  • RMD 37.08
  • EPS
  • EQR 2.62
  • RMD 8.91
  • Revenue
  • EQR $3,010,100,000.00
  • RMD $5,021,529,000.00
  • Revenue This Year
  • EQR $6.07
  • RMD $10.15
  • Revenue Next Year
  • EQR $4.33
  • RMD $7.50
  • P/E Ratio
  • EQR $26.70
  • RMD $27.51
  • Revenue Growth
  • EQR 3.81
  • RMD 9.54
  • 52 Week Low
  • EQR $59.41
  • RMD $179.42
  • 52 Week High
  • EQR $78.83
  • RMD $263.05
  • Technical
  • Relative Strength Index (RSI)
  • EQR 52.92
  • RMD 68.10
  • Support Level
  • EQR $69.96
  • RMD $237.00
  • Resistance Level
  • EQR $71.04
  • RMD $247.35
  • Average True Range (ATR)
  • EQR 1.23
  • RMD 5.53
  • MACD
  • EQR 0.18
  • RMD 1.93
  • Stochastic Oscillator
  • EQR 43.75
  • RMD 93.87

About EQR Equity Residential of Beneficial Interest

Equity Residential owns a portfolio of 311 apartment communities with around 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: